The PYR1 antibody is a polyclonal immunoglobulin developed to detect and study the Arabidopsis thaliana pyrabactin resistance 1 (PYR1) protein, a key abscisic acid (ABA) receptor involved in plant stress responses and developmental regulation. PYR1 belongs to the PYR/PYL/RCAR family of ABA receptors, which mediate ABA-dependent inhibition of type 2C protein phosphatases (PP2Cs) to regulate drought tolerance, seed dormancy, and stomatal closure .
Western Blot: Detects endogenous PYR1 in Arabidopsis extracts at ~21 kDa .
ELISA Titer: Exceeds 1:500,000, confirming high specificity .
Functional Assays: Validated in co-immunoprecipitation studies with ABA signaling components (e.g., ABI1, BAK1) .
PYR1 antibodies have been critical in elucidating ABA receptor mechanisms:
ABA-Induced Interactions: Co-immunoprecipitation studies demonstrate ABA-enhanced binding between PYR1 and PP2Cs (e.g., ABI1), which is essential for downstream signal transduction .
Dimerization Regulation: Phosphorylation of PYR1 by BAK1 kinase reduces homodimer formation, promoting active monomeric PYR1-ABA complexes that inhibit PP2Cs .
Stress Response Studies: Used to quantify PYR1 expression under drought and salinity, informing crop engineering strategies .
Chemical Screens: Facilitated high-throughput identification of ABA receptor agonists/antagonists using in vitro interaction assays .
Species Specificity: Limited cross-reactivity outside Arabidopsis and close relatives .
Quantitative Challenges: Semi-quantitative WB data require complementary methods (e.g., ELISA) for precise quantification .
Emerging Applications: Potential use in synthetic biology for designing ABA-responsive circuits in crops .
KEGG: spo:SPBC17G9.11c
STRING: 4896.SPBC17G9.11c.1
PYR1 (Pyrabactin Resistance 1) is a member of the PYR/PYL/RCAR protein family that functions as an abscisic acid (ABA) sensor in plants. As an ABA receptor (specifically RCAR11), PYR1 plays a crucial role in mediating plant responses to environmental stresses such as drought and salinity. Understanding PYR1 function is fundamental to elucidating plant hormone signaling networks and developing stress-resistant crop varieties. PYR1 is also known as ABI1-binding protein 6 and is part of the regulatory components of ABA receptor family .
PYR1 antibodies are typically polyclonal antibodies raised in rabbits against synthetic peptides derived from Arabidopsis thaliana PYR1 sequence (UniProt: O49686, TAIR: At4g17870). These antibodies are generally provided in lyophilized format and require reconstitution before use. The expected molecular weight of the target protein is approximately 21 kDa when detected via Western blotting .
PYR1 antibodies have confirmed reactivity with Arabidopsis thaliana proteins. They are predicted to cross-react with Brassica species due to sequence homology, though this cross-reactivity might require experimental verification for specific applications. No confirmed exceptions from predicted reactivity are currently known .
For optimal Western blot results with PYR1 antibody:
Prepare protein samples (approximately 150 μg of total protein from Arabidopsis thaliana)
Extract proteins using buffer containing 50 mM Tris, 150 mM NaCl, 0.5% Triton X-100, 2 mM DTT, 1 mM PMSF, and protease inhibitors
Separate proteins on 10% SDS-PAGE and transfer to PVDF membrane using semi-dry transfer for 2 hours
Block membranes with 5% nonfat milk in 1× TBST for 1 hour at room temperature with agitation
Incubate with primary PYR1 antibody at 1:10,000 dilution for 1 hour at room temperature
Wash membranes once for 15 minutes and three times for 5 minutes in TBS-T
Incubate with secondary antibody (anti-rabbit IgG HRP conjugated) at 1:50,000 dilution for 1 hour
Wash and develop using ECL according to manufacturer's instructions
For optimal reconstitution and storage:
Add 50 μL of sterile water to the lyophilized antibody
Store reconstituted antibody at -20°C
Make aliquots of reconstituted antibody to avoid repeated freeze-thaw cycles
Prior to opening, briefly spin tubes to collect material that may adhere to the cap or sides
Working dilutions should be prepared fresh before use
After reconstitution, the antibody remains stable for several months when properly stored
To study ABA signaling under different stress conditions:
Design experiments with plants subjected to various stresses (drought, salt, cold)
Collect tissue samples at different time points following stress exposure
Extract proteins using the buffer described in FAQ 2.1
Perform Western blot analysis using PYR1 antibody to detect changes in PYR1 protein levels
Complement protein level analysis with gene expression studies
Consider co-immunoprecipitation experiments to study PYR1 interaction with other proteins in the ABA signaling pathway
Compare PYR1 levels and interactions between wild-type and mutant plants to understand functional significance
This approach allows researchers to correlate PYR1 protein levels with stress response mechanisms and identify potential regulatory pathways .
When designing co-immunoprecipitation experiments:
Ensure buffer conditions maintain protein-protein interactions (typically milder detergents)
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Incubate cleared lysates with PYR1 antibody at a 1:50 to 1:100 dilution
Add protein A/G beads to capture antibody-protein complexes
Wash extensively to remove non-specific interactions
Elute complexes and analyze by Western blot or mass spectrometry
Always include appropriate controls (non-immune IgG, input samples)
Consider using crosslinking approaches for transient interactions
Verify results with reciprocal co-IPs using antibodies against interacting partners
These strategies help identify genuine interaction partners of PYR1 in the ABA signaling pathway .
| Challenge | Potential Cause | Solution |
|---|---|---|
| Weak or no signal | Insufficient protein loading | Increase protein concentration to at least 150 μg total protein |
| Degraded antibody | Prepare fresh aliquots and avoid freeze-thaw cycles | |
| Inefficient transfer | Optimize transfer conditions (time, voltage, buffer composition) | |
| High background | Insufficient blocking | Increase blocking time or try alternative blocking agents |
| Too high antibody concentration | Dilute primary antibody further (1:15,000-1:20,000) | |
| Inadequate washing | Increase wash duration and number of washes | |
| Multiple bands | Cross-reactivity | Confirm specificity using PYR1 knockout/knockdown samples |
| Protein degradation | Add additional protease inhibitors to extraction buffer | |
| Post-translational modifications | Verify with phosphatase or deglycosylation treatments |
When optimizing Western blot conditions, always run a positive control sample (Arabidopsis wild-type tissue) alongside experimental samples to validate antibody performance .
To validate antibody specificity:
Compare signal between wild-type and PYR1 knockout/knockdown plants
Perform peptide competition assays using the immunogenic peptide
Test antibody reactivity in tissues known to have differential PYR1 expression
Compare results from multiple antibodies targeting different epitopes of PYR1
Correlate protein detection with mRNA expression data
Confirm expected molecular weight (21 kDa) using molecular weight markers
Verify subcellular localization through immunofluorescence and cell fractionation
These validation steps ensure confidence in experimental results and minimize misinterpretation due to non-specific antibody binding .
When interpreting variations in PYR1 protein levels:
Normalize PYR1 signal to appropriate loading controls (e.g., actin, tubulin, GAPDH)
Quantify band intensity using densitometry software
Perform statistical analysis across biological replicates (minimum n=3)
Consider post-translational modifications that might affect protein detection
Correlate protein levels with physiological responses and phenotypic changes
Compare protein data with gene expression analysis (qRT-PCR, RNA-seq)
Evaluate results in context of known ABA signaling mechanisms
Consider tissue-specific and developmental variations in PYR1 expression
These approaches ensure robust and meaningful interpretation of changes in PYR1 protein levels in response to experimental treatments .
When comparing PYR1 expression across species or mutant lines:
Evaluate antibody cross-reactivity with the target protein in each species
Adjust protein extraction protocols for tissue-specific differences
Consider evolutionary conservation of the epitope recognized by the antibody
Account for different isoforms or homologs that might be present in different species
Use appropriate molecular weight markers to confirm target protein identity
Include positive controls from confirmed reactive species (e.g., Arabidopsis thaliana)
Optimize antibody concentration for each species separately
Consider complementary approaches (mass spectrometry, gene expression) to validate findings
These considerations help ensure accurate comparative analysis of PYR1 expression patterns across different biological systems .
To comprehensively study protein-protein interactions:
Combine co-immunoprecipitation with PYR1 antibody with mass spectrometry to identify novel interaction partners
Use proximity ligation assays to visualize and quantify PYR1 interactions in situ
Employ bimolecular fluorescence complementation (BiFC) to validate direct interactions
Perform chromatin immunoprecipitation (ChIP) if PYR1 is suspected to interact with DNA-binding proteins
Use protein microarrays probed with PYR1 antibody to screen for potential interactors
Implement FRET/FLIM analysis with fluorescently-tagged proteins to study dynamics of interactions
Correlate interaction data with functional outcomes using genetic approaches
This multi-technique approach provides robust evidence for functional protein-protein interactions in the ABA signaling network .
To study post-translational modifications of PYR1:
Use phospho-specific antibodies if phosphorylation sites on PYR1 are known
Perform 2D gel electrophoresis followed by Western blotting to separate modified forms
Treat samples with phosphatases, deubiquitinases, or deglycosylases before immunoblotting
Use mobility shift assays to detect modifications that alter protein migration
Perform immunoprecipitation with PYR1 antibody followed by mass spectrometry to identify modifications
Compare modification patterns under different stress conditions or hormone treatments
Correlate modifications with PYR1 activity using functional assays
Generate site-specific mutants to validate the importance of modification sites
These approaches help elucidate how post-translational modifications regulate PYR1 function in response to environmental stimuli .